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Summary
Background Few studies have reported long-term data on mortality rates for children admitted to hospital with 
pneumonia in Africa. We examined trends in case fatality rates for all-cause clinical pneumonia and its risk factors 
in Malawian children between 2001 and 2012.
Methods Individual patient data for children (<5 years) with clinical pneumonia who were admitted to hospitals 
participating in Malawi’s Child Lung Health Programme between 2001 and 2012 were recorded prospectively on a 
standardised medical form. We analysed trends in pneumonia mortality and children’s clinical characteristics, and 
we estimated the association of risk factors with case fatality for children younger than 2 months, 2–11 months of 
age, and 12–59 months of age using separate multivariable mixed eﬀ ects logistic regression models.
Findings Between November, 2012, and May, 2013, we retrospectively collected all available hard copies of yellow 
forms from 40 of 41 participating hospitals. We examined 113 154 pneumonia cases, 104 932 (92∧7%) of whom had 
mortality data and 6903 of whom died, and calculated an overall case fatality rate of 6·6% (95% CI 6·4–6·7). The 
case fatality rate signiﬁ cantly decreased between 2001 (15·2% [13·4–17·1]) and 2012 (4·5% [4·1–4·9]; ptrend<0·0001). 
Univariable analyses indicated that the decrease in case fatality rate was consistent across most subgroups. In 
multivariable analyses, the risk factors signiﬁ cantly associated with increased odds of mortality were female sex, 
young age, very severe pneumonia, clinically suspected Pneumocystis jirovecii infection, moderate or severe 
underweight, severe acute malnutrition, disease duration of more than 21 days, and referral from a health centre. 
Increasing year between 2001 and 2012 and increasing age (in months) were associated with reduced odds of 
mortality. Fast breathing was associated with reduced odds of mortality in children 2–11 months of age. However, 
case fatality rate in 2012 remained high for children with very severe pneumonia (11·8%), severe undernutrition 
(15·4%), severe acute malnutrition (34·8%), and symptom duration of more than 21 days (9·0%).
Interpretation Pneumonia mortality and its risk factors have steadily improved in the past decade in Malawi; 
however, mortality remains high in speciﬁ c subgroups. Improvements in hospital care may have reduced case 
fatality rates though a lack of suﬃ  cient data on quality of care indicators and the potential of socioeconomic and 
other improvements outside the hospital precludes adequate assessment of why case-fatality rates fell. Results 
from this study emphasise the importance of eﬀ ective national systems for data collection. Further work combining 
this with data on trends in the incidence of pneumonia in the community are needed to estimate trends in the 
overall risk of mortality from pneumonia in children in Malawi.
Funding Bill & Melinda Gates Foundation.
Copyright © Lazzerini et al. Open Access article distributed under the terms of CC BY.
Introduction
Pneumonia is the leading cause of morbidity and 
mortality in post-neonatal children under 5 years of age.1 
According to the most recent estimates,1 0·9 million 
children died of pneumonia in 2013, and more than 95% 
of these deaths happened in low-income and middle-
income countries.1,2
Few data are available to show the epidemiology and 
public health burden of paediatric pneumonia cases in 
African hospitals. A recent systematic review3 identiﬁ ed 
only 11 studies reporting data on mortality from acute 
lower respiratory infections in hospitals within the 
African region; these reports were unpublished, with 
very few exceptions,4 and observation times were limited 
to 2–3 years.3
Malawi is currently one of the poorest countries in 
sub-Saharan Africa. However, according to national 
statistics,5 major progress was made in the past 15 years, 
and Malawi is on track to reach the Millennium 
Development Goal 4 of a two-thirds reduction in 
under-5 year mortality from 1990 to 2015.
In 2000, the Malawi Ministry of Health implemented a 
standardised medical chart for children younger than 
5 years who were admitted to hospital with clinical 
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pneumonia. These data have been routinely collected 
prospectively but never comprehensively analysed. We 
have analysed the available individual patient data from 
hospitals in Malawi that implemented this routine 
system of data collection between 2001 and 2012, with the 
objective of describing trends in case fatality rates for all-
cause clinical pneumonia and its risk factors in children 
younger than 5 years.
Methods
Study design and participants
In 2000, the Malawi Ministry of Health’s Acute Respiratory 
Infection unit (ARI) and the International Union Against 
Tuberculosis and Lung Disease implemented the Child 
Lung Health Programme (CLHP),6,7 which included two 
key elements: national clinical pneumonia management 
guidelines8 adapted from WHO guidelines;9,10 and the 
implementation of a standardised patient chart (the 
yellow form) to be used as an oﬃ  cial medical ﬁ le for each 
child admitted to hospital for pneumonia. CLHP clinical 
pneumonia was deﬁ ned according to Malawi ARI 
guidelines (panel). The yellow form contains individual 
patient data such as demographic variables, clinical 
signs and symptoms, pneumonia disease severity, 
comorbidities, treatments received, and outcomes 
(appendix pp 3–4). The following criteria were used 
for CLHP programme participation: an active ARI 
programme; leadership commitment; one health worker 
responsible for implementation (local ARI coordinator); 
and about 100 000 population catchment area.6 District 
government hospitals were prioritised for participation in 
CLHP, and by 2004, 22 of 23 district hospitals and three 
of four central government hospitals were enrolled.6 In 
2005, with the support of the Scottish Government, the 
programme expanded to include the Christian Hospital 
Association of Malawi hospitals, which are mostly ﬁ rst-
level, fee-based facilities. By 2012, 22 of 23 district 
hospitals, three of four central hospitals, and 16 of 
37 Christian Hospital Association of Malawi facilities 
were participating in the CLHP (appendix p 5).
From 2001 to 2005, major external support was provided 
to the CLHP: health staﬀ  were trained in the programme, 
which included a follow-up refresher session and on-the-
job training; international expert technical guidance that 
focused on maintaining data quality, accuracy, and 
completeness was provided twice annually; and 
Research in context
Evidence before this study
A recent systematic review identiﬁ ed only 11 studies reporting 
data on mortality in children admitted to hospital with acute 
lower respiratory infections in the African region, and with very 
few exceptions, reports were unpublished, and with an 
observation time limited to 2–3 years. We also searched PubMed 
using the following search strategy: (“Pneumonia”[Mesh] OR 
“Respiratory Tract Infections”[Mesh]) AND (“Child”[Mesh] OR 
(“child”[MeSH Terms] OR “child”[All Fields] OR “children”[All 
Fields]) OR (“pediatrics”[MeSH Terms] OR “pediatrics”[All Fields] 
OR “paediatric”[All Fields]) OR (“pediatrics”[MeSH Terms] OR 
“pediatrics”[All Fields] OR “pediatric”[All Fields])) AND 
(“Malawi”[MeSH Terms] OR “Malawi”[All Fields]) from inception 
to July 8, 2015, with no language restrictions. We found 
68 studies, none of which covered the range of years and 
numbers of hospitals of our study.
Added value of this study
We have analysed an individual patient database of hospitalised 
cases of pneumonia in children in Malawi, collected over a 
12 year period. The data shows a clear decline in case fatality 
rate between 2001 and 2012, although this rate remains high 
in some subgroups (children with very severe pneumonia, 
severe undernutrition, severe acute malnutrition, and symptom 
duration >21 days).
Implications of all the available evidence
Overall, our study supports the ﬁ nding from the Millennium 
Development Goal 4 indicators that under-5 mortality has 
signiﬁ cantly decreased in Malawi in recent years. Further 
research is needed to link hospital data with community-based 
pneumonia data and to investigate quality of care provided to 
children at diﬀ erent levels of the health system.
Panel: Classiﬁ cation of severity of clinical pneumonia10
Non-severe pneumonia (2–59 months of age)*
• Cough, diﬃ  culty breathing, or both
• Fast breathing for age†
• No lower chest indrawing and no danger signs‡
Severe pneumonia (<2 months of age)
• Cough, diﬃ  culty breathing, or both, and
• Lower chest indrawing or fast breathing for age*†
• No danger signs‡
Severe pneumonia (2–59 months of age)
• Cough, diﬃ  culty breathing, or both
• Lower chest indrawing
• No danger signs‡
• Might or might not have fast breathing for age†
Very severe pneumonia (0–59 months of age)
• Cough, diﬃ  culty breathing, or both
• At least one danger sign‡
• Might or might not have fast breathing for age†
• Lower chest indrawing
* Young infants younger than 2 months do not have a non-severe pneumonia 
classiﬁ cation. †60 breaths per min or more if child is younger than 2 months; 50 breaths 
per min or more if child is 2–11 months old; 40 breaths per min or more if child is 
12–59 months old. ‡Danger signs are any of the following: central cyanosis, severe 
respiratory distress (grunting, head nodding, severe chest indrawing), stridor, a general 
danger sign (inability to drink, breastfeed, or both, lethargy or unconsciousness, 
convulsions), apnoea (if child is 0–2 months of age). Wheeze is not considered in 
diagnosis or classiﬁ cation of severity of pneumonia.10
See Online for appendix
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programme managers met regularly to review their 
work.6 The CLHP also provided an uninterrupted supply 
of antibiotic drugs for pneumonia treatment.6 Between 
2006 and 2008, the programme was gradually transitioned 
to the Ministry of Health, whereas external assistance 
focused on enrolling facilities from the Christian Hospital 
Association of Malawi using previous approaches. In 
2009, the Ministry of Health assumed primary control 
and arranged supervision visits and follow-up trainings 
according to local needs and available funding.
Between November, 2012, and May, 2013, the study 
authors and data collectors employed by PACHI (the 
local research organisation conducting the study) 
collected all available hard copies of yellow forms from 
40 of the 41 participating hospitals, where the forms were 
stored (usually under the supervision of the local ARI 
coordinator). Standardised data cleaning and data entry, 
including systematic quality assurance checks, were 
done by data entry clerks and nurses under close 
supervision by ML, RB, and SS. Conﬁ dentiality was 
maintained by de-identifying all ﬁ les before database entry.
This study was approved by the Ethics Committee of 
University College London (project number 2006/002) and 
by the National Health Sciences Research Committee of 
Malawi (protocol number 941). 
Descriptive and statistical analyses
Our descriptive analyses focused on the following 
outcomes: annual case fatality rates, annual case fatality 
rates in predeﬁ ned population subgroups, and changes in 
children’s characteristics with time. Young infants 
(deﬁ ned as infants younger than 2 months) and children 
age 2–59 months were analysed separately since 
pneumonia classiﬁ cation and treatment diﬀ ers in these 
two groups, according to WHO guidelines.8–10 Weight-for-
age was analysed according to WHO 2006 standards 
applied retrospectively to the dataset.11 WHO moderate 
undernutrition and severe undernutrition were deﬁ ned 
as weight-for-age ranging between –3 and –2 SD from the 
median and weight-for-age less than –3 SD from the 
median, respectively. The clinical diagnosis of severe 
acute malnutrition was made prospectively during patient 
care on the basis of visible signs of wasting or oedema of 
both feet as per Malawi guidelines.8–10 Pneumonia and 
fast breathing were deﬁ ned according to standard WHO 
criteria (panel). Fever was deﬁ ned as body temperature 
greater than 38°C.
We compared mortality rates in patients for whom we 
had data on basic demographic variables and risk factor 
variables with rates in patients with missing data using 
the χ² statistic, Fisher’s exact test, or t test, as appropriate, 
to informally investigate the likelihood that missing data 
could substantially bias subsequent analyses. We also did 
sensitivity analyses assuming diﬀ erent probabilities of 
mortality for the cases missing data on mortality relative 
to cases with data (0, 0∙1x, 0∙5x, 2x, 10x, and 1, where x is 
the probability of mortality in cases with data).
We compared rates by year using the χ² test for trend 
(Cochrane–Armitage test). Univariable logistic regression 
was used to calculate odds ratios (ORs) for mortality 
associated with each risk factor in each age group and in 
diﬀ erent population subgroups; survival time until death 
was not recorded (appendix p 3–4), precluding Cox 
regression.
For all statistical tests, a p value of 0·05 or less 
(two-sided) was considered signiﬁ cant. We used 
Stata version 13·1 for all analyses.12
Three multivariable logistic regression models were 
created to determine risk factors for mortality for 
pneumonia cases admitted to hospital in children younger 
than 2 months, age 2–11 months, and age 12–59 months 
separately. We used bootstrap resampling of stepwise 
backwards elimination with a p value cutoﬀ  greater than 
0∙05 for leaving the model to build multivariable models 
for each age group.13,14 All variables except HIV and malaria 
(risk factors for which too much data were missing) were 
initially entered into each of 100 bootstrap replications, 
and variables that were selected in more than 50% of the 
replications were included in the ﬁ nal models.13,14 As 
pneumonia cases were included from 40 hospitals, 
mortality could be correlated within hospitals. Likelihood 
ratio test conﬁ rmed the clustered nature of the data, and 
we used mixed eﬀ ects logistic regression models to 
account for this. Results of the multivariable logistic 
regression analyses are presented as adjusted OR (AOR) 
with 95% CI. Events per variable15 and area under the 
receiver-operator-characteristic (ROC) curve are presented 
as measures of model adequacy and goodness of ﬁ t.
To reduce bias and loss of information due to missing 
data, we used multiple imputation with the assumption 
that data was missing at random. Data showed evidence 
of clustering, so we used REALCOM impute software to 
impute missing data.16 Variables in the multiple 
imputation models included the mortality outcome, risk 
Figure 1: Study ﬂ ow diagram
115 240 cases of pneumonia in the database
113 154 available for analysis
104 932 cases for which data are available for 
the analysis of mortality
2086 ineligible
672 duplicates
565 older than 5 years
598 age unknown
251 date of admission unknown or not 
during 2001–12
8222 excluded
7741 data on final outcome missing
481 treatment failure
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Younger than 2 months (n=10 860) 2–59 months (n=102 294) Total (%) n=113 154
Survived (%) n=9247 Died (%) n=712 Missing (%) n=901 Survived (%) n=88 782 Died (%) n=6191 Missing (%) n=7321
Region of Malawi
Northern 1641 (18%) 128 (18%) 104 (12%) 16 914 (19%) 1059 (17%) 1101 (15%) 20 947 (19%)
Central 4098 (44%) 334 (65%) 480 (53%) 38 247 (43%) 2456 (40%) 3166 (43%) 48 781 (43%)
Southern 3508 (38%) 250 (35%) 316 (35%) 33 612 (38%) 2676 (43%) 3053 (42%) 43 415 (38%)
Missing 0 0 1 (<1%) 9 (<1%) 0 1 (<1%) 11 (<1%)
Type of facility
District 7250 (78%) 556 (78%) 616 (68%) 71 089 (80%) 4993 (81%) 4710 (64%) 89 214 (79%)
Central 888 (10%) 79 (11%) 61 (7%) 7978 (9%) 554 (9%) 639 (9%) 10 199 (9%)
Mission or rural 1109 (12%) 77 (11%) 223 (25%) 9706 (11%) 644 (10%) 1971 (27%) 13 730 (12%)
Missing 0 0 1 (<1%) 9 (<1%) 0 1 (<1%) 11 (<1%)
Sex
Female 3880 (42%) 303 (43%) 380 (42%) 38 858 (44%) 3097 (50%) 3933 (54%) 49 639 (44%)
Male 5109 (55%) 386 (54%) 475 (53%) 48 128 (54%) 2947 (48%) 3121 (43%) 60 978 (54%)
Missing 258 (3%) 23 (3%) 46 (5%) 1796 (2%) 147 (2%) 267 (4%) 2537 (2%)
Severity of pneumonia in children age 2–59 months
Very severe N/A N/A N/A 19 186 (22%) 3804 (61%) 1916 (26%) 24 906 (24%)
Severe N/A N/A N/A 66 872 (75%) 2206 (36%) 4904 (67%) 73 982 (72%)
Non-severe N/A N/A N/A 1581 (2%) 46 (1%) 273 (4%) 1900 (2%)
Pneumocystis jirovecii N/A N/A N/A 169 (<1%) 74 (1%) 36 (1%) 279 (<1%)
Other N/A N/A N/A 65 (<1%) 2 (<1%) 0 68 (<1%)
Missing N/A N/A N/A 909 (1%) 58 (1%) 192 (3%) 1159 (1%)
Severity of pneumonia in infants <2 months
Very severe 4082 (44%) 528 (74%) 338 (38%) N/A N/A N/A 4948 (46%)
Severe 5010 (54%) 165 (23%) 506 (56%) N/A N/A N/A 5681 (52%)
Pneumocystis jirovecii 15 (<1%) 3 (<1%) 5 (1%) N/A N/A N/A 23 (<1%)
Other 3 (<1%) 0 0 N/A N/A N/A 3 (<1%)
Missing 137 (2%) 16 (2%) 52 (6%) N/A N/A N/A 205 (2%)
Days with symptoms (before admission)
<21 days 8234 (89%) 637 (90%) 781 (87%) 79 003 (89%) 5260 (85%) 6284 (86%) 100 199 (89%)
>21 days 167 (2%) 14 (2%) 17 (2%) 2284 (3%) 336 (5%) 255 (4%) 3073 (3%)
Missing 846 (9%) 61 (9%) 103 (11%) 7495 (8%) 595 (10%) 782 (11%) 9882 (9%)
Antibiotic treatment prior to hospital attendance
No 4844 (52%) 359 (50%) 438 (49%) 43 805 (49%) 2534 (41%) 3213 (44%) 55 193 (49%)
Yes 2090 (23%) 175 (25%) 203 (23%) 23 040 (26%) 2080 (34%) 1934 (26%) 29 522 (26%)
Missing 2313 (25%) 178 (25%) 260 (29%) 21 937 (25%) 1577 (26%) 2174 (30%) 28 439 (25%)
Referral type
Self-referral 6037 (65%) 365 (51%) 516 (57%) 59 626 (67%) 3157 (51%) 4309 (59%) 74 010 (65%)
Referral by health centre 1959 (21%) 241 (34%) 222 (25%) 17 380 (20%) 2088 (34%) 1728 (24%) 23 618 (21%)
Missing 1251 (14%) 106 (15%) 163 (18%) 11 776 (13%) 946 (15%) 1284 (18%) 15 526 (14%)
Pneumonia in past 12 months
No 8262 (89%) 623 (88%) 748 (83%) 66 047 (74%) 4612 (75%) 4991 (68%) 85 283 (75%)
Yes 223 (2%) 16 (2%) 25 (3%) 16 481 (19%) 1024 (17%) 1278 (18%) 19 047 (17%)
Missing 762 (8%) 73 (10%) 128 (14%) 6254 (7%) 555 (9%) 1052 (14%) 8824 (8%)
Previous hospital admission for pneumonia in past 12 months
No 8333 (90%) 622 (87%) 754 (84%) 71 541 (81%) 4944 (80%) 5390 (74%) 91 584 (81%)
Yes 128 (1%) 13 (2%) 10 (1%) 10 777 (12%) 660 (11%) 816 (11%) 12 404 (11%)
Missing 786 (9%) 77 (11%) 137 (15%) 6464 (7%) 587 (10%) 1115 (15%) 9166 (8%)
Measles in past 2 months
No 7914 (86%) 596 (84%) 681 (76%) 74 872 (84%) 5068 (82%) 5321 (73%) 94 452 (84%)
Yes 25 (<1%) 0 3 (<1%) 1182 (1%) 91 (2%) 121 (2%) 1422 (1%)
Missing 1308 (14%) 116 (16%) 217 (24%) 12 728 (14%) 1032 (17%) 1879 (26%) 17 280 (15%)
(Table 1 continues on next page)
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Younger than 2 months (n=10 860) 2–59 months (n=102 294) Total (%) n=113 154
Survived (%) n=9247 Died (%) n=712 Missing (%) n=901 Survived (%) n=88 782 Died (%) n=6191 Missing (%) n=7321
(Continued from next page)
Weight for age category
Normal 7868 (85%) 472 (66%) 702 (78%) 64 641 (73%) 2765 (45%) 4784 (65%) 81 232 (72%)
Moderate underweight* 570 (6%) 107 (15%) 75 (8%) 11 939 (13%) 1208 (20%) 1028 (14%) 14 927 (13%)
Severe underweight* 248 (3%) 58 (8%) 23 (3%) 7097 (8%) 1338 (22%) 740 (10%) 9504 (8%)
Missing 561 (6%) 75 (11%) 101 (11%) 5105 (6%) 880 (14%) 769 (11%) 7491 (7%)
Severe acute malnutrition†
Absent 7892 (85%) 578 (81%) 675 (75%) 74 570 (84%) 4649 (75%) 5269 (72%) 93 633 (83%)
Present 21 (<1%) 6 (1%) 5 (1%) 1047 (1%) 482 (8%) 151 (2%) 1712 (2%)
Missing 1334 (14%) 128 (18%) 221 (25%) 13 165 (15%) 1060 (17%) 1901 (26%) 17 809 (16%)
Temperature
Afebrile 6488 (70%) 445 (63%) 604 (67%) 47 949 (54%) 3400 (55%) 3714 (51%) 62 600 (55%)
Febrile (>38°C) 1355 (15%) 143 (20%) 113 (13%) 27 105 (31%) 1699 (27%) 2139 (29%) 32 554 (29%)
Missing 1404 (15%) 124 (17%) 184 (20%) 13 728 (16%) 1092 (18%) 1468 (20%) 18 000 (16%)
Mean (SD, range), °C 37·3
(0·9, 30·0–42·2)
37·2
(1·5, 31·0–42·0)
37·3
(0·9, 33·5–41·1)
37·8
(1·2, 30·0–45·0)
37·7
(1·2, 30·7–42·0)
37·8
(1·2, 30·2–42·0)
37·8
(1·2, 30·0–45·0)
Median, °C (IQR) 37·2
(36·8–38·0)
37·2
(36·8–38·0)
37·1
(36·7–38·0)
37·8
(37·0–38·7)
37·8
(37·0–38·5)
37·8
(37·0–38·7)
37·8
(37·0–38·6)
Season
Dry (May–October) 4206 (46%) 385 (54%) 439 (49%) 42 675 (48%) 3046 (49%) 3735 (51%) 54 486 (48%)
Wet (November–April) 5019 (54%) 326 (46%) 455 (51%) 45 925 (52%) 3124 (51) 3543 (48%) 58 392 (52%)
Missing 22 (<1%) 1 (<1%) 7 (1%) 182 (<1%) 21 (<1%) 43 (1%) 276 (<1%)
Respiratory rate
Normal 1362 (15%) 83 (12%) 184 (20%) 4523 (5%) 364 (6%) 467 (6%) 6983 (6%)
Fast breathing‡ 6903 (75%) 543 (76%) 543 (60%) 75 674 (85%) 5139 (83%) 5534 (76%) 94 336 (83%)
Missing 982 (11%) 86 (12%) 174 (19%) 8585 (10%) 688 (11%) 1320 (18%) 11 835 (11%)
Mean (SD, range) 67 (12·7, 2–198) 69 (14·2, 20–155) 65 (13·6, 2–180) 61 (12·3, 2–270) 64 (14·3, 5–180) 60 (13·3, 3–195) 62 (12·7, 2–270)
Median (IQR) 66 (61–72) 68 (62–75) 64 (59–70) 60 (54–68) 62 (56–70) 60 (52–67) 60 (54–68)
Malaria blood ﬁ lm status
Negative 1103 (12%) 50 (7%) 79 (9%) 16 196 (18%) 974 (16%) 968 (13%) 19 370 (17%)
Positive 266 (3%) 17 (2%) 18 (2%) 7708 (9%) 562 (9%) 490 (7%) 9061 (8%)
Missing 7878 (85%) 645 (91%) 804 (89%) 64 878 (73%) 4655 (75%) 5863 (80%) 84 723 (75%)
HIV status
Negative 643 (7%) 34 (5%) 68 (8%) 5441 (6%) 292 (5%) 448 (6%) 6926 (6%)
Positive 68 (1%) 7 (1%) 7 (1%) 1248 (1%) 241 (4%) 151 (2%) 1722 (2%)
Missing 8536 (92%) 671 (94%) 826 (92%) 82 093 (93%) 5658 (91%) 6722 (92%) 104 506 (92%)
Outcome§
Died within 24 h of 
admission
0 404 (57%) 0 0 2966 (48%) 0 3370 (3%)
Died after 24 h of 
admission
0 308 (43%) 0 0 3225 (52%) 0 3533 (3%)
Left against advice 389 (4%) 0 0 2585 (3%) 0 0 2974 (3%)
Transferred 31 (<1%) 0 0 373 (<1%) 0 0 404 (<1%)
Discharged alive 8827 (96%) 0 0 85 824 (97%) 0 0 94 651 (84%)
Treatment failure at 48 h 0 0 5 (1%) 0 0 310 (4%) 315 (<1%)
Treatment failure at day 5 0 0 6 (1%) 0 0 160 (2%) 166 (<1%)
Missing 0 0 890 (99%) 0 0 6851 (94%) 7741 (7%)
Data are n (%) unless otherwise indicated. N/A=not appropriate. *Moderate undernutrition was deﬁ ned as weight-for-age less than –2 SD from the mean based on the WHO 2006 growth reference standards; 
severe undernutrition was deﬁ ned as weight-for-age less than –3 SD based on the WHO 2006 growth reference standards·10 †The diagnosis of severe acute malnutrition was made prospectively during patient care 
by the health worker based on visible signs of severe wasting or oedema of both feet or by National Guidelines in Malawi·8,10 ‡60 breaths per min of more if <2 months old, ≥50 breaths per min if 2–11 months old; 
40 breaths per min or more if 12–59 months old. §Left against advice and Transferred are counted as Survived as the child did not die in the facility and we are only able to measure deaths in the facility (ie, calculate 
facility case fatality rate rather than population-level mortality). However, treatment failures are counted as missing for mortality as they are more likely to have died (although we do not have any data on this).
Table 1: Study population characteristics
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factors of mortality included in the multivariable models, 
and key variables that were found to be predictors of 
missingness including region and type of facility. The 
HIV and malaria variables were excluded for having too 
many missing data to be imputed. Once we imputed the 
data in REALCOM, the data were uploaded into Stata for 
analysis using the commands “mi estimate: xtmelogit”.12
We used separate logistic regression models to analyse 
the available data for HIV. Scenarios were generated to 
assess the eﬀ ect of possible trends of HIV prevalence 
and case fatality rates in HIV-negative cases on overall 
case fatality rates, assuming odds of mortality in 
HIV-positive pneumonia cases 5∙9 times higher than the 
odds of mortality in HIV-negative cases17 in ﬁ ve scenarios 
and changing the odds in another scenario.
Role of the funding source
The funder of the study had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding authors had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
All clinical pneumonia cases registered on the yellow 
forms with an age younger than 5 years were included 
(ﬁ gure 1). Of the 113 154 unique cases within the dataset 
that were available for analysis (ﬁ gure 1), 102 294 cases 
were aged 2–59 months and 10 860 cases were younger 
than 2 months. The number of cases with each potential 
risk factor in young infants and children who survived, 
died, or for whom data on case fatality were missing are 
listed in table 1. Overall, less than 20% of data were 
missing for all but three variables: previous antibiotic 
treatment (25·1% of data were missing), malaria blood 
ﬁ lm (74·8% of data were missing), and HIV status 
(92·3% of data were missing). The number of annual 
cases can be found in the appendix (p 6). District 
hospitals contributed the largest number of cases 
(appendix p 7).
6903 deaths were registered between 2001 and 2012, an 
overall case fatality rate of 6·6% (95% CI 6·4–6·7). The 
case fatality rate decreased with time (15·2% [13·4–17·1] 
in 2001 vs 4·5% [4·1–4·9] in 2012; ptrend<0·0001; ﬁ gure 2), 
even when mortality was assumed to be ten times higher 
in cases for whom mortality data were missing than in 
cases with mortality data.
In the multivariable model, the following risk factors 
were signiﬁ cantly associated with high mortality in 
infants younger than 2 months (table 2): very severe 
pneumonia (compared with severe pneumonia); referral 
from a health centre (compared with self-referral); 
moderately underweight and severely underweight for 
age (compared with normal weight for age); and febrile 
temperature (compared with afebrile temperature). 
Wet season (compared with dry season), increasing year 
from 2001 to 2012, and increasing age (1 month of age 
compared with 0 months of age) were associated with 
lower mortality. Severe acute malnutrition, which was 
signiﬁ cantly associated with higher mortality, was the 
only signiﬁ cant variable in univariable analyses that was 
not included in the multivariable model.
In children aged 2–11 months, our ﬁ ndings were 
similar to those of young infants with respect to the 
above-cited risk factors (table 2). The following risk 
factors were also signiﬁ cantly associated with increased 
odds of mortality: location of hospital in the 
southern region; female sex; clinically suspected 
Pneumocystis jirovecii infection; more than 21 days with 
symptoms; and severe acute malnutrition. Fast breathing 
(compared with normal breathing) was the only 
additional factor associated with lower mortality in the 
multivariable model. Previous antibiotic treatment, 
Figure 2: (A) Case fatality rate for children with pneumonia in Malawi (missing data not included) and 
(B) worst and best case scenario case fatality rates on the basis of diﬀ erent assumptions about case fatality 
for cases with missing data on fatality, 2001–12
Error bars show 95% CI.
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Younger than 2 months 2–11 months 12–59 months
Univariable analyses OR 
(95% CI)
Multivariable model 
n=6878¶|| AOR (95% CI)
Univariable analyses OR 
(95% CI)
Multivariable model 
n=34 427¶** AOR (95% CI)
Univariable analyses 
OR (95% CI)
Multivariable model 
n=28 952¶†† AOR 
(95% CI)
Geographical region of Malawi
Northern 1·00 ·· 1·00 1·00 1·00 ··
Central 1·00 (0·70–1·43) ·· 1·00 (0·75–1·32) 1·10 (0·85–1·44) 1·21 (0·85–1·70) ··
Southern 0·94 (0·66–1·35) ·· 1·50 (1·13–1·98) 1·42 (1·09–1·84) 1·37 (0·97–1·94) ··
Type of health-care facility
District 1·00 ·· 1·00 ·· 1·00 ··
Central 1·05 (0·75–1·47) ·· 1·23 (0·94–1·60) ·· 1·05 (0·78–1·42) ··
Mission/rural 1·13 (0·67–1·92) ·· 1·34 (0·84–2·13) ·· 0·77 (0·46–1·30) ··
Sex
Male 1·00 ·· 1·00 1·00 1·00 1·00
Female 1·04 (0·89–1·22) ·· 1·32 (1·24–1·41) 1·51 (1·38–1·65) 1·27 (1·16–1·41) 1·35 (1·18–1·54)
Pneumonia classiﬁ cation‡
Non-severe N/A N/A 1·00 1·00 1·00 1·00
Severe 1·00 1·00 1·56 (1·01–2·43) 2·20 (1·02–4·71) 0·73 (0·48–1·09) 1·60 (0·74–3·43)
Very severe 4·11 (3·42–4·95) 3·60 (2·81–4·60) 9·44 (6·10–14·62) 12·22 (5·70–26·17) 4·30 (2·86–6·44) 9·38 (4·37–20·09)
Pneumocystis jirovecii 5·47 (1·55–19·33) 5·80 (0·71–47·38) 19·93 (11·72–33·89) 21·35 (8·86–51·46) 5·26 (2·25–12·30) 6·25 (1·62–24·05)
Days with symptoms
<21 days 1·00 ·· 1·00 1·00 1·00 ··
>21 days 1·10 (0·63–1·92) ·· 1·99 (1·72–2·29) 1·35 (1·08–1·67) 2·36 (1·90–2·92) ··
Previous antibiotic treatment
No 1·00 ·· 1·00 ·· 1·00
Yes 1·14 (0·94–1·38) ·· 1·48 (1·38–1·59) ·· 1·66 (1·48–1·86) ··
Type of referral
Self-referral 1·00 1·00 1·00 1·00 1·00 1·00
From health centre 2·02 (1·70–2·41) 1·85 (1·50–2·29) 2·02 (1·88–2·17) 1·72 (1·56–1·88) 2·85 (2·55–3·18) 2·23 (1·94–2·57)
Previous pneumonia in past 12 months
No 1·00 ·· 1·00 ·· 1·00 ··
Yes 0·96 (0·58–1·62) ·· 1·09 (1·00–1·19) ·· 0·86 (0·76–0·98) ··
Previous hospital admission due to pneumonia
No 1·00 ·· 1·00 ·· 1·00 ··
Yes 1·39 (0·78, 2·48) ·· 1·17 (1·05–1·30) ·· 0·83 (0·72–0·96) ··
Measles in past 2 months
No * ·· 1·00 1·00 1·00 ··
Yes * ·· 1·19 (0·93–1·52) 1·31 (0·92–1·87) 0·87 (0·55–1·37) ··
Weight for age
Normal weight 1·00 1·00 1·00 1·00 1·00 1·00
Moderately underweight 3·20 (2·55–4·03) 3·37 (2·54–4·47) 2·60 (2·39–2·82) 2·27 (2·04–2·53) 2·07 (1·80–2·37) 1·70 (1·43–2·02)
Severely underweight 3·82 (2·82–5·18) 3·76 (2·56–5·53) 4·24 (3·89–4·62) 3·42 (3·04–3·85) 5·00 (4·40–5·68) 3·23 (2·72–3·84)
Severe acute malnutrition
Absent 1·00 ·· 1·00 1·00 1·00 1·00
Present 3·91 (1·55, 9·86) ·· 6·62 (5·63–7·79) 2·85 (2·18–3·75) 10·04 (8·51–11·84) 4·19 (3·28–5·35)
Malaria blood ﬁ lm positive
No 1·00 † 1·00 † 1·00 †
Yes 1·47 (0·82–2·65) † 1·03 (0·90–1·18) † 1·52 (1·27–1·83) †
HIV status
Negative 1·00 † 1·00 † 1·00 †
Positive 1·95 (0·83–4·56) † 3·93 (3·11–4·96) † 3·43 (2·51–4·69) †
Body temperature
Afebrile 1·00 1·00 1·00 ·· 1·00 ··
Febrile (>38°C) 1·56 (1·28–1·91) 1·52 (1·20–1·93) 0·94 (0·87–1·01) ·· 0·83 (0·75–0·93) ··
(Table 2 continues on next page)
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previous hospital admission with pneumonia, and HIV-
positive status were signiﬁ cantly associated with 
increased mortality in univariable analyses but not 
included in the multivariable model.
Findings in children aged 12–59 months were similar 
to those in children age 2–11 months, although region, 
number of days with symptoms, measles in the past 
2 months, and respiratory category were not in the 
multivariable model whereas season was, with wet 
season signiﬁ cantly associated with higher mortality 
(table 2).
Results from the multiple imputation models 
indicated that missing data had little eﬀ ect on the 
estimates from the complete case analysis. Only the 
association of clinically diagnosed P jirovecii with 
mortality in children younger than 2 months was 
statistically signiﬁ cant with multiple imputation, 
whereas this risk factor was not statistically signiﬁ cant 
without multiple imputation (appendix p 22 and 
table 2).
Between 2001 and 2012, the proportion of children with 
characteristics associated with a higher odds of mortality 
decreased; these characteristics included very severe 
pneumonia of any age group, children 2–59 months old 
with moderate and severe underweight for age, and 
children receiving antibiotics before admission to 
hospital (table 3). During this period, the proportion of 
children with characteristics associated with lower odds 
of death (children diagnosed or admitted to hospital with 
pneumonia in the past year) increased.
Overall, we found the same decreasing trend in 
mortality when cases where stratiﬁ ed by age, region, 
hospital type, sex, pneumonia severity, weight-for-age, 
duration of illness, type of access to hospital, previous 
treatment, prior history of pneumonia or hospital 
admission, and HIV status (table 4, appendix pp 8–21).
Despite this progress, case fatality rates in 2012 remained 
high for children of all ages with very severe pneumonia 
(11·8%; 10·3% for infants younger than 2 months, 16·5% 
for infants aged 2–11 months, and 6·1% for children aged 
12–59 months), severe undernutrition (15·4%), and severe 
acute malnutrition (34·8%), and for children with 
symptoms lasting more than 21 days (9·0%; ).
The additional logistic regression model used with the 
available HIV data showed that the reduction in 
pneumonia mortality per year was statistically 
signiﬁ cant even if HIV status was included in the model 
(AOR of mortality per year 0∙89 [95% CI 0∙85–0∙93], 
p<0∙0001, n=7842). When using the conservative 
assumption that all cases missing HIV data were HIV-
negative, this result remains signiﬁ cant (AOR of 
mortality per year 0∙883 [0∙875–0∙892], p<0∙0001, 
n=103 184).
The possible eﬀ ects on pneumonia case fatality rates of 
changes in HIV prevalence with time are shown in the 
appendix (p 30). None of the scenarios supported the 
hypothesis that the decrease in pneumonia case fatality 
rate can predominantly be explained by a decrease in 
HIV prevalence.
Discussion
Our study shows that overall mortality for children 
admitted to hospital with pneumonia in Malawi has 
signiﬁ cantly decreased between 2001 and 2012. The 
decrease in case fatality rate was gradual and consistent 
across regions, hospital types, sex, age, pneumonia 
severity, type of access to hospital, type of previous 
treatment, and previous history of pneumonia or hospital 
Younger than 2 months 2–11 months 12–59 months
Univariable analyses OR 
(95% CI)
Multivariable model 
n=6878¶|| AOR (95% CI)
Univariable analyses OR 
(95% CI)
Multivariable model 
n=34 427¶** AOR (95% CI)
Univariable analyses 
OR (95% CI)
Multivariable model 
n=28 952¶†† AOR 
(95% CI)
(Continued from previous page)
Season
Dry (May–October) 1·00 1·00 1·00 ·· 1·00 1·00
Wet (November–April) 0·71 (0·60–0·82) 0·72 (0·59–0·88) 0·90 (0·85–0·96) ·· 1·08 (0·98–1·20) 1·57 (1·01–1·32)
Respiratory category
Normal 1·00 ·· 1·00 1·00 1·00 ··
Fast breathing§ 1·27 (1·00–1·61) ·· 1·05 (0·93–1·18) 0·80 (0·67–0·95) 0·79 (0·59–1·06) ··
Year admitted to hospital 
per year, 2001–12
0·886 (0·861–0·911) 0·909 (0·876–0·944) 0·888 (0·878–0·898) 0·915 (0·900–0·929) 0·885 (0·870, 0·901) 0·915 (0·893–0·938)
Age, months 0·563 (0·480–0·660) 0·567 (0·458–0·703) 0·954 (0·943–0·965) 0·947 (0·932 – 0·963) 0·991 (0·986, 0·996) ··
OR=odds ratio. AOR=adjusted odds ratio. ··=data not included in ﬁ nal multivariable model. N/A=not applicable. *Model did not converge because none of the cases that died had measles (and only 25 cases of 
measles in total). †Not entered into multivariable model building process as too much missing data. ‡See panel for deﬁ nitions. §More than 60 breaths per min for children younger than 2 months; 50 breaths per 
min or more for children 2–11 months old; and 40 breaths per min for children 12–59 months old. ¶Number of cases in multivariable model are less than total number of cases because of missing data for one or 
more variables in the model. ||445 deaths; nine variables; 49 events per variable; area under ROC curve 0·77. **2520 deaths, 15 variables, 168 events per variable; area under ROC curve 0·81. ††1004 deaths; ten 
variables, 100 events per variable; area under ROC curve 0·83.
Table 2: Univariable analyses and mixed eﬀ ects multivariable regression analysis showing odds ratio (95% CI) for risk factors for mortality in children younger than 2 months, 
2–11 months of age, and 12–59 months of age
Articles
www.thelancet.com/lancetgh   Vol 4   January 2016 e65
admission. Furthermore, the association of decreasing 
case fatality rate by study year was statistically signiﬁ cant 
in our multivariable models for each age group. In 
parallel, the prevalence of mortality risk factors (very 
severe pneumonia and malnutrition) decreased, and the 
prevalence of potentially protective factors increased. 
Despite this progress, we saw no signiﬁ cant decrease in 
mortality for some categories of children, such as 
Year of study Slope (SE); ptrend
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Female sex 674 
(44∧3%; 
41∧9–
46∧9)
1516 
(47∧4%; 
45∧7–
49∧1)
2334 
(47∧7%; 
46∧3–
49∧1)
1877 
(46∧0%; 
44∧5–
47∧5)
3449 
(45∧4%; 
44∧3–
46∧5)
3493 
(44∧7%; 
43∧6–
45∧8)
4758 
(46∧2%; 
45∧2–
47∧1)
4268 
(44∧9%; 
43∧9–
45∧9)
6522 
(45∧4%; 
44∧7–
46∧3)
6907 
(43∧5%; 
42∧8–
44∧3)
7878 
(44∧2%; 
43∧5–
44∧9)
5131 
(43∧5%; 
42∧6–
44∧4)
–0∧3% (0∧1%); p<0∧0001
Young infants 
(<2 months)
110 
(7∧2%; 
6∧0–
8∧6)
230 
(7∧2%; 
6∧3–
8∧1)
514 
(10∧4%; 
9∧6–
11∧3)
371 
(9∧0%; 
8∧8–
10∧1)
735 
(9∧5%; 
8∧8–
10∧1)
946 
(11∧8%; 
11∧2–
12∧6)
1388 
(13∧1%; 
12∧5–
13∧8)
817 
(8∧4%; 
7∧9–
9∧0)
1591 
(10∧8%; 
10∧3–
11∧3)
1331 
(8∧2%; 
7∧8–
8∧6)
1675 
(9∧2%; 
8∧8–
9∧6)
930 
(7∧7%; 
7∧3–
8∧2)
–0∧1% (0∧03%); p<0∧0001
Very severe pneumonia
Age 2–59 months 431 
(30∧7%; 
28∧4–
33∧2)
989 
(33∧5%; 
31∧8–
35∧3)
1281 
(29∧2%; 
27∧9–
30∧5)
1054 
(28∧4%; 
27∧0–
29∧9)
1981 
(28∧4%; 
27∧4–
29∧5)
1863 
(26∧7%; 
25∧7–
27∧8)
2415 
(26∧6%; 
25∧7–
27∧6)
2266 
(25∧9%; 
25∧0–
26∧8)
3143 
(24∧2%; 
23∧5–
24∧9)
3095 
(21∧0%; 
20∧3–
21∧6)
3348 
(20∧4%; 
19∧8–
21∧0)
2604 
(23∧7%; 
22∧9–
24∧5)
–1∧0% (0∧1%); p<0∧0001
Age <2 months 77 
(70∧6%; 
61∧4–
78∧5)
158 
(70∧9%; 
64∧5–
76∧5)
295 
(57∧8%; 
53∧5–
62∧1)
195 
(53∧4%; 
48∧3–
58∧5)
413 
(57∧7%; 
54∧0–
61∧3)
478 
(51∧3%; 
48∧1–
54∧5)
691 
(50∧8%; 
(48∧1–
53∧4)
410 
(50∧7%; 
47∧2–
54∧1)
687 
(43∧6%; 
41∧2–
46∧1)
492 
(37∧8%; 
35∧2–
40∧5)
613 
(37∧4%; 
35∧1–
39∧8)
340 
(37∧4%; 
34∧4–
40∧6)
–2∧9% (0∧2%); p<0∧0001
Weight-for-age
Moderately 
underweight*
264 
(17∧4%; 
15∧5–
19∧3)
610 
(19∧0%; 
17∧6–
19∧3)
810 
(16∧5%; 
15∧4–
17∧5)
680 
(16∧5%; 
15∧4–
17∧7)
1142 
(14∧7%; 
13∧9–
15∧5)
1148 
(14∧4%; 
13∧6–
15∧2)
1414 
(13∧3%; 
12∧7–
14∧0)
1314 
(13∧6%; 
12∧9–
14∧3)
1850 
(12∧6%; 
12∧1–
13∧1)
1994 
(12∧3%; 
11∧8–
12∧8)
2068 
(11∧3%; 
10∧9–
11∧8)
1400 
(11∧6%; 
11·1–
12·2)
–0∧6% (0∧03% <0∧0001
Severely 
underweight*
182 
(12∧0%; 
10∧4–
13∧7)
458 
(14∧2%; 
13∧1–
15∧5)
573 
(11∧6%; 
10∧8–
12∧6)
503 
(12∧2%; 
11∧2–
13∧2)
863 
(11∧1%; 
10∧4–
11∧8)
838 
(10∧5%; 
9∧8–
11∧2)
915 
(8∧6%; 
8∧1–
9∧2)
872 
(9∧0%; 
8∧4–
9∧6)
1162 
(7∧9%; 
7·5–
8·4)
1119 
(6∧9%; 
6·5–
7·3)
1131 
(6∧2%; 
5·8–
6·5)
727 
(6∧0%; 
5·6–
6·5)
–0∧7% (0∧03%); <0∧0001
Severe acute 
malnutrition†
70 
(5∧2%; 
4·2–6·6)
187 
(6∧1%; 
5·3–7·0)
174 
(3∧8%; 
3·2–4·3)
90 
(2∧4%; 
2·0–3·0)
152 
(2∧2%; 
1·9–2·6)
128 
(1∧8%; 
1·5–2·1)
198 
(2∧1%; 
1·9–2·5)
137 
(1∧6%; 
1·4–1·9)
193 
(1∧5%; 
1·3–1·8)
166 
(1∧3%; 
1·1–1·5)
116 
(0∧8%; 
0·7–0·9)
75
(0·8%; 
0·6–1·0)
–0∧3% (0∧02%) <0∧0001
Symptoms for >21 days 44 
(3∧0%; 
2·2–4·0)
70 
(2∧2%; 
1·8–2·8)
125 
(2∧7%; 
2·3–3·2)
150 
(3∧9%; 
3·3–4·6)
291 
(4∧1%; 
3·7–4·6)
248 
(3∧4%; 
3·0–3·8)
341 
(3∧5%; 
3·2–3·9)
327 
(3∧6%; 
3·3–4·1)
414 
(3∧0%; 
2·8–3·3)
381 
(2∧6%; 
2·3–2·8)
336 
(2∧1%; 
1·8–2·3)
282 
(2∧6%; 
2·3–2·9)
–0∧1% (0∧02%); <0∧0001
Self-referral to hospital 1134 
(77∧8%; 
75·6–
79·9)
2429 
(78∧9%; 
77·5–
80·3)
3390 
(76∧0%; 
74·7–
77·2)
2725 
(73∧5%; 
72·0–
74·9)
5145 
(75∧4%; 
74·4–
76·4)
5194 
(73∧6%; 
72·5–
74·6)
6770 
(73∧1%; 
72·2–
74·0)
6279 
(75∧2%; 
74·2–
76·1)
9822 
(76∧1%; 
75·4–
76·9)
10 506 
(75∧7%; 
74·9–
76·4)
11 787 
(76∧8%; 
76·1–
77·4)
7970 
(7∧89%; 
78·1–
79·7)
–0∧2% (0∧05%); <0∧0001
No antibiotic before 
hospital admission
1022 
(73∧5%; 
71·1–
75·8)
2103 
(75∧4%; 
73·7–
76·9)
2818 
(69∧5%; 
68·1–
70·9)
2187 
(67∧1%; 
65·5–
68·7)
4240 
(68∧3%; 
67·2–
69·5)
3765 
(61∧8%; 
60·3–
62·8)
5035 
(62∧6%; 
61·6–
63·7)
4722 
(65∧5%; 
64·4–
66·6)
7358 
(64∧5%; 
63·6–
65·3)
7637 
(63∧6%; 
62·7–
64·5)
8020 
(63∧0%; 
62·2–
63·9)
5730 
(66∧6%; 
65·6–
67·6)
-0∧6% (0∧1%); <0∧0001
Pneumonia in past 
12 months
238 
(15∧8%; 
14·1–
17·8)
498 
(15∧6%; 
14·4–
16·9)
655 
(13∧8%; 
12·8–
14·8)
657 
(16∧7%; 
15·6–
17·9)
1372 
(19∧2%; 
18·3–
20·1)
1248 
(16∧2%; 
15·4–
17·0)
1700 
(17∧1%; 
16·4–
17·9)
1749 
(19∧1%; 
18·3–
19·9)
2372 
(17∧3%; 
16·6–
17·9)
2757 
(18∧6%; 
(18·0–
19·3)
3253 
(20∧2%; 
19·6–
20·8)
2278 
(21∧0%; 
20·2–
21·8)
0∧5% (0∧04%); <0∧0001
Hospital admission in 
past 12 months
135 
(9∧0%; 
7·6–
10·5)
302 
(9∧5%; 
8·5–
10·6)
387 
(8∧2%; 
7·4–
9·0)
408 
(10∧4%; 
9·5–
11·4)
872 
(12∧2%; 
11·5–
13·0)
882 
(11∧5%; 
10·8–
12·2)
1128 
(11∧4%; 
10·8–
12·0)
1172 
(12∧8%; 
12·2–
13·5)
1532 
(11∧2%; 
10·7–
11·7)
1575 
(10∧7%; 
10·2–
11·2)
2268 
(14∧1%; 
13·6–
14·7)
1557 
(14∧3%; 
13·7–
15·0)
0∧4% (0∧04%); <0∧0001
Measles in past 
2 months
11 
(0∧8%; 
0·4–1·4)
17 
(0∧6%; 
0·3–0·9)
18 
(0∧4%; 
0·2–0·6)
13 
(0∧4%; 
(0·2–0·6)
34 
(0∧5%; 
(0·3–0·7)
43 
(0∧6%; 
0·4–0·8)
57 
(0∧6%; 
0·5–0·8)
71 
(0∧8%)
(0·7–1·0)
125 
(1∧0%; 
0·8–1·2)
749 
(5∧7%; 
5·3–6·1)
186 
(1∧3%; 
1·1–1·5)
70 
(0∧7%; 
0·6–0·9)
0∧2% (0∧01%); <0∧0001
Data are n (%; 95% CI of the proportion). Only variables with less than 20% missing data are included in the analysis, with the exception of antibiotic treatment before hospital admission (rate of missing data 
25%); ptrend was calculated for 2001–12. *Moderate undernutrition was deﬁ ned as weight-for-age less than –2 SD from the mean based on the WHO 2006 growth reference standards; severe undernutrition was 
deﬁ ned as weight-for-age less than –3 SD based on the WHO 2006 growth reference standards·10 †The diagnosis of severe acute malnutrition was made prospectively during patient care by the health worker based 
on visible signs of severe wasting or oedema of both feet or by National Guidelines in Malawi·8,10
 Table 3: Percentage of children presenting with possible factors aﬀ ecting the risk of pneumonia mortality, by study year
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children with very severe pneumonia, severe under-
nutrition, severe acute malnutrition, and symptoms 
lasting more than 21 days. Our ﬁ ndings also suggest 
possible sex inequality (girls had higher case fatality rates 
than boys) and regional disparities (southern Malawi 
with a higher mortality than other regions).
Several factors might have aﬀ ected our results. The 
retrospective nature of this study might have biased 
results in several ways. First, variables were limited to 
those routinely collected on the yellow form whereas 
information on other potentially important factors such as 
vaccination status and socioeconomic condition, or height 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Region
Northern 92 (17%) 75 (11%) 88 (9%) 102 (10%) 137 (8%) 132 (7%) 123 (6%) 90 (5%) 127 (5%) 84 (4%) 72 (3%) 45 (3%)
Central 74 (16%) 157 (11%) 165 (8%) 129 (10%) 349 (12%) 302 (9%) 239 (5%) 213 (6%) 300 (6%) 312 (5%) 251 (3%) 207 (4%)
Southern 59 (13%) 118 (13%) 169 (10%) 128 (9%) 218 (9%) 125 (6%) 321 (10%) 363 (10%) 408 (7%) 365 (7%) 353 (5%) 261 (5%)
Hospital
Mission 2 (13%) 4 (50%) 1 (25%) 3 (15%) 20 (13%) 39 (13%) 119 (7%) 153 (7%) 150 (6%) 97 (6%) 70 (4%) 40 (5%)
District 223 (15%) 344 (11%) 394 (9%) 350 (9%) 545 (9%) 453 (7%) 492 (7%) 441 (7%) 649 (6%) 583 (5%) 543 (4%) 431 (4%)
Central 0 2 (50%) 27 (16%) 6 (8%) 139 (11%) 67 (10%) 72 (6%) 72 (9%) 36 (5%) 81 (5%) 63 (3%) 42 (6%)
Sex
Male 111 (13%) 166 (10%) 206 (8%) 182 (9%) 349 (9%) 258 (6%) 337 (7%) 323 (7%) 397 (6%) 371 (5%) 320 (4%) 255 (4%)
Female 114 (18%) 183 (13%) 213 (10%) 171 (10%) 336 (11%) 284 (9%) 326 (7%) 330 (8%) 411 (7%) 366 (6%) 341 (5%) 244 (5%)
Age
<2 months 23 (21%) 28 (12%) 60 (12%) 34 (10%) 66 (10%) 77 (9%) 96 (7%) 57 (8%) 74 (5%) 67 (6%) 64 (4%) 53 (6%)
2–59 months 202 (15%) 322 (11%) 362 (9%) 325 (9%) 638 (10%) 482 (7%) 587 (7%) 609 (7%) 761 (6%) 694 (5%) 612 (4%) 460 (4%)
Severity
Very severe, 2–59 months 121 (29%) 224 (24%) 257 (21%) 204 (20%) 402 (21%) 274 (15%) 371 (16%) 381 (18%) 450 (16%) 383 (14%) 368 (12%) 289 (12%)
Severe, 2–59 months 74 (8%) 91 (5%) 97 (4%) 112 (5%) 210 (5%) 191 (4%) 187 (3%) 214 (4%) 298 (3%) 292 (3%) 230 (2%) 159 (2%)
Very severe, <2 months 23 (30%) 24 (15%) 47 (17%) 30 (16%) 52 (13%) 57 (13%) 69 (10%) 42 (11%) 58 (9%) 43 (10%) 44 (8%) 33 (10%)
Severe, <2 months 0 4 (6%) 12 (6%) 4 (2%) 12 (5%) 19 (5%) 23 (4%) 14 (4%) 16 (2%) 21 (3%) 17 (2%) 17 (3%)
Weight
Normal 131 (12%) 184 (9%) 254 (8%) 199 (7%) 404 (8%) 323 (6%) 425 (5%) 417 (6%) 524 (5%) 493 (4%) 422 (3%) 317 (3%)
Moderately underweight 60 (24%) 81 (14%) 83 (11%) 72 (11%) 146 (14%) 112 (10%) 113 (9%) 124 (10%) 144 (8%) 131 (7%) 130 (7%) 92 (7%)
Severely underweight 34 (19%) 85 (20%) 85 (16%) 88 (19%) 154 (20%) 124 (16%) 145 (17%) 125 (15%) 167 (16%) 137 (14%) 124 (12%) 104 (15%)
Malnutrition
Severe acute malnutrition 22 (34%) 45 (26%) 46 (28%) 31 (36%) 47 (34%) 34 (28%) 56 (31%) 43 (34%) 76 (45%) 41 (30%) 19 (18%) 24 (35%)
Days with symptoms
<21 days 208 (15%) 333 (11%) 374 (9%) 302 (9%) 600 (9%) 477 (7%) 570 (7%) 566 (7%) 720 (6%) 645 (5%) 572 (4%) 432 (4%)
>21 days 12 (29%) 9 (14%) 16 (14%) 20 (14%) 49 (18%) 34 (15%) 37 (12%) 31 (10%) 48 (13%) 46 (14%) 17 (6%) 23 (9%)
Type of referral
Self-referral 131 (12%) 207 (9%) 244 (8%) 216 (8%) 386 (8%) 296 (6%) 356 (6%) 304 (5%) 394 (4%) 368 (4%) 315 (3%) 247 (3%)
Referred from a health 
centre
83 (26%) 120 (19%) 132 (13%) 93 (10%) 236 (15%) 180 (10%) 230 (10%) 253 (13%) 297 (11%) 265 (9%) 231 (7%) 181 (9%)
Previous treatment
No previous antibiotic 126 (13%) 209 (10%) 243 (9%) 169 (8%) 328 (8%) 236 (7%) 287 (6%) 251 (6%) 287 (4%) 319 (5%) 225 (3%) 173 (3%)
Previous antibiotic 74 (21%) 105 (16%) 114 (10%) 106 (10%) 227 (12%) 181 (8%) 217 (8%) 224 (10%) 314 (8%) 244 (6%) 246 (6%) 174 (7%)
Previous pneumonia in the past 12 months
No 189 (15%) 296 (11%) 339 (9%) 286 (9%) 525 (10%) 451 (7%) 507 (7%) 519 (8%) 629 (6%) 539 (5%) 489 (4%) 370 (5%)
Yes 33 (14%) 49 (10%) 65 (10%) 51 (8%) 111 (9%) 80 (7%) 118 (7%) 86 (5%) 135 (6%) 132 (5%) 98 (3%) 71 (3%)
Admission to hospital for pneumonia in the last 12 months
No 203 (15%) 319 (12%) 361 (9%) 302 (9%) 556 (9%) 470 (7%) 551 (7%) 541 (7%) 666 (6%) 570 (5%) 526 (4%) 403 (5%)
Yes 19 (15%) 26 (9%) 44 (12%) 34 (9%) 71 (9%) 58 (7%) 68 (6%) 63 (6%) 90 (6%) 94 (7%) 59 (3%) 40 (3%)
HIV status
Negative 0 0 3 (6%) 3 (8%) 10 (9%) 22 (9%) 35 (6%) 56 (7%) 74 (6%) 55 (5%) 39 (3%) 21 (4%)
Positive 0 1 (50 %) 0 2 (13%) 15 (21%) 24 (23%) 33 (16%) 38 (19%) 57 (21%) 29 (12%) 27 (11%) 16 (10%)
Data are n (%) of cases recorded to have died in hospital (see appendix pp 8–21 for graphs of this data and n (%) of cases recorded to have survived).
Table 4: Case fatality rates for key categories of potential risk factors for pneumonia mortality in Malawian hospitals, 2001–12
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of children (for a better assessment of nutritional status) 
were not available. Second, selection bias is possible; the 
study sample excluded a few smaller facilities, and a 
proportion of pneumonia cases in each facility might have 
been missed, or records could have been lost. Given that it 
is not possible to trace these cases, we do not know how 
these factors aﬀ ected our case fatality results. In a routine 
setting such as this study, indicators such as prior 
antibiotic treatment and previous pneumonia relied only 
on verbal report; measurement of temperature, respiratory 
rate, and weight might have been aﬀ ected by equipment 
accuracy, measurement error, or both.
Case fatality rates might have been aﬀ ected either by 
misrecording of deaths (numerator) or misrecording of 
total pneumonia cases (denominator). Selective under-
recording of deaths, with case selection towards more 
healthy cases, might have occurred for cases of very 
severe pneumonia dying only a few hours after hospital 
admission, or for other reasons. To this end we found a 
signiﬁ cant increase in the proportion of cases with 
unknown outcome over time (appendix, p 24). However, 
even assuming a worst case scenario where all cases with 
an unknown outcome were ten times more likely to die 
than cases with outcome recorded, the trend of decreasing 
case fatality rate was still observed (ﬁ gure 2). The 
multivariable logistic regression models with multiple 
imputation also support a decreasing case fatality rate 
(appendix, p 22). That pneumonia misdiagnoses might 
have occurred is possible; however, misdiagnoses are 
unlikely to have systematically increased over time to the 
extent of explaining the observed trends in case fatality 
rate reductions. Case deﬁ nition did not change with 
time—although it changed later (WHO revised the 
pneumonia classiﬁ cation criteria in 2013)—and data 
quality eﬀ orts were made during this time period.6
In terms of quality of data, we note signiﬁ cant increases 
in the percentage of cases with missing data with time, 
both on non-clinical variables and on variables 
necessitating patient measurement (appendix, pp 26–
29); however, in the latter case these trends appear to be 
independent of case severity. These ﬁ ndings might 
suggest that the data quality decreased over time, perhaps 
due to the transition away from external support.
Despite these limitations, the study has the strength of 
representing a large sample from many hospitals in 
Malawi during a long period of time. Overall, our 
ﬁ ndings are consistent with the results of a recent 
systematic review,3 in which the case fatality rate for 
children admitted to hospital with pneumonia in the 
African region was shown to be 3·9% (95% CI 2·7–5·5). 
According to a previous analysis of 24 hospitals using the 
yellow forms, case fatality rates for pneumonia in 
children had fallen from 18·6% in 2000 to 8·4% in 2005.6 
No other studies from sub-Saharan Africa report on 
trends of case fatality rates for hospital admissions for 
pneumonia over such a long period. In a review18 of 
trends in overall mortality from respiratory diseases in 
Latin America between 1998 and 2009, investigators 
reported that mortality in children younger than 5 years 
had also signiﬁ cantly decreased. The results of this study 
are in line with the progress documented by oﬃ  cial 
country indicators of Malawi (appendix, p 31), showing 
an improvement in many socioeconomic and health 
indicators. Several factors might have contributed to 
these achievements: extensive external support provided 
by CLHP between 2000 and 2008 (training, supervision, 
and supply of antibiotic drugs);6 improved use of oxygen 
therapy;19 strengthened community-case management;20 
and scale-up of antiretroviral drugs for HIV treatment.21,22
Overall, our multivariable results are mainly in line 
with previous analyses from low-income and middle-
income countries in Africa and Asia. Severity of 
pneumonia, malnutrition, and young age are well known 
risk factors for pneumonia mortality.23 In a systematic 
review23 of 23 studies (20 835 children), female sex was 
associated with a 15% increase in the risk of death. The 
association between clinically suspected P jirovecii 
pneumonia and high risk of death has been conﬁ rmed in 
other studies.24–26 Longer symptom duration has also 
been associated with higher mortality in Central African 
Republic, Zimbabwe, and Papua New Guinea,27–29 and 
seasonality in pneumonia mortality has been observed in 
a nearby country (Kenya),30 and might be explained by a 
higher prevalence of non-severe viral infections in a 
certain part of the year or by other factors.31 Our ﬁ nding 
of lower mortality in children (2–11 months of age) with 
fast breathing, after adjusting for confounders, could 
suggest that these children are less severely ill than those 
without fast breathing, an observation consistent with 
other studies in the Central African Republic27 and 
Indonesia.32
The observation that children referred to hospital from 
a health centre were more likely to die than those who 
were not referred could have multiple explanations: more 
severe cases might tend to seek care at the nearest facility, 
usually a health centre, rather than directly travelling 
longer distances to the closest hospital, or incorrect 
outpatient treatment, including delayed referral, might 
aﬀ ect mortality. Findings on fever should be interpreted 
in view of temperature being recorded only once at time 
of admission to hospital.
Results from this study have implications for practice 
by emphasising the importance of eﬀ ective national 
systems of data collection. Importantly, results from this 
database, which contains only cases of hospitalised 
pneumonia, cannot be generalised to the epidemiology 
of pneumonia mortality in the community, which is 
estimated to be greater.3 Large projects, including both 
hospital-based and community-based data are needed to 
estimate the overall risk of mortality from pneumonia in 
children in Malawi.
Despite these encouraging ﬁ ndings, our analysis also 
reveals areas for priority action. Case fatality rates for 
hospitalised pneumonia in Malawi remain high for 
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children with very severe pneumonia, malnutrition, long 
duration of symptoms, and young age. A high case 
fatality rate for hospitalised pneumonia in girls compared 
with boys, with a lower number of girls than boys 
admitted to hospital, suggests possible sex in equalities in 
access to care or quality of treatment. This aspect, 
together with regional diﬀ erences in case fatality rates, 
deserves further assessment. The high proportion of 
children accessing the hospital through self-referral 
(78%), suggests that more needs to be done to strengthen 
primary health-care services and to improve coordination 
between levels of care.
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